Contact

Jack Pace

White & Case (New York)

Partner

Jack Pace is a partner and member of White & Case’s Global Competition and Commercial Litigation Practice Groups. He concentrates on complex commercial litigation and counseling in the areas of antitrust and trade regulation. Mr. Pace has extensive experience defending companies in complex, multi-jurisdictional class actions, including those involving claims under the antitrust laws, consumer protection statutes and Title VII. Mr. Pace regularly represents clients in the pharmaceutical, financial services, agricultural and insurance industries. Mr. Pace is an Associate Editor of Antitrust Magazine and regularly publishes articles on antitrust law, class certification and other complex commercial litigation topics. Mr. Pace is a member of White & Case’s Knowledge and Technology Committee and has many years of experience advising clients on e-discovery issues such as document retention policies, document collection and discovery management. Mr. Pace is a member of the Board of Directors of Reach Out and Read of Greater New York, a not-for-profit organization focusing on pediatric literacy. He also serves as liaison in connection with the Firm’s work with inMotion, a not-for-profit organization that provides free legal and social services to low income women in New York City, and supervises the Firm’s pro bono special education cases.

Distinctions

Nominee, 2022 Antitrust Writing Awards: Business, Concerted Practices

Nominee, 2020 Antitrust Writing Awards: Business, Intellectual Property

Nominee, 2020 Antitrust Writing Awards: Academic, General Antitrust

Nominee, 2017 Antitrust Writing Awards: Business, Procedure

Contact

Linked authors

Fanny Abouzeid

White & Case (Brussels)

Belgium 4 contributions 1300 visits

Adam Acosta

White & Case (Washington)

United States 11 contributions 1800 visits

Kevin Adam

Suffolk University Law School

United States 9 contributions 2758 visits

Reem Albakr

White & Case (Riyadh)

Saudi Arabia 1 contribution 886 visits

Melinda Anderson

White & Case (New York)

United States 1 contribution 401 visits

3296 | Events

12 Sep 2022 Washington, D.C. 2022 Bill Kovacic Antitrust Salon See documents

28 Sep 2021 Webinar Bill Kovacic Antitrust Salon #2 The Future of Antitrust Case Law: What the Courts Could Say About the New Trends? See documents

31 May 2019 New York The Global Antitrust Economics Conference See documents

Videos

Jack Pace (White & Case) — Jack Pace 31 May 2019 New York

Articles

2757 Bulletin

Robert Milne, Jack Pace, Kevin Adam, Jaclyn Phillips The US District Court for the Northern District of California’s dismissal of an antitrust case against a popular gaming console manufacturer sheds light on the viability of refusal to deal claims against platform technology companies (Sony)

15 July 2022 60

This article has been nominated for the 2023 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. The recent dismissal of an antitrust case against Sony relating to the sale of digital video games on the company’s PlayStation Store could shed light on the (...)

Mark J. Gidley, George Paul, Jack Pace, Kathryn Jordan Mims, Kristen O’Shaughnessy, Kevin Adam, Jaclyn Phillips, Abdul Hafiz, Erin McNamee The US President Joe Biden signs an executive order instructing more than a dozen federal agencies to promptly tackle some of the most pressing competition problems across the national economy

9 July 2021 607

A new Executive Order signed by President Biden includes 72 initiatives instructing more than a dozen federal agencies, including the US Department of Justice and the Federal Trade Commission, to, according to the White House’s Fact Sheet, "promptly tackle some of the most pressing competition (...)

Jack Pace, Kristen O’Shaughnessy, Robert Milne, Peter J. Carney, Michael Gallagher, Mark J. Gidley, Kevin Adam The US Congress proposes a package of bills on drug pricing, including changes to the treatment of reverse payments, product hopping, sham petitions, and patent dancing

21 April 2021 198

What’s next for drug pricing in the US? Proposals to alter antitrust and patent laws may signal a renewed focus on drug pricing by federal lawmakers, while the growing web of state laws is expected to increase compliance challenges for the pharmaceutical industry. What’s changing? A new (...)

Jack Pace, Scott Hershman, Andrew Hammond, Ian Cuillerier, Tripp Odom, Edward So, Pratin Vallabhaneni The US DoJ releases a positive Business Review Letter blessing the amendments of the International Swaps and Derivatives Association to address interest rate benchmarks (International Swaps and Derivatives Association)

1 October 2020 455

For the thousands of financial institutions anxiously watching the discontinuation and transition from certain interbank offered rates (“IBORs”), 2020 just got a little less chaotic. On Thursday, October 1, 2020, the United States Department of Justice Antitrust Division issued its highly (...)

Mark J. Gidley, Noah A. Brumfield, Jack Pace, Kristen O’Shaughnessy, Dan Grossbaum, Bryan D. Gant The US State of California becomes the first State to enact legislation rendering certain pharmaceutical patent litigation settlement agreements presumptively anticompetitive

7 October 2019 197

This article has been nominated for the 2020 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. On October 7, 2019, California became the first state to enact legislation— Assembly Bill 824 (“AB 824”)—rendering certain pharmaceutical patent litigation (...)

Agatha Koprowski, Jack Pace, Max Shterngel, Owen Pell, Robert Milne, Scott Hershman The New York Court of Appeals holds that state law cannot reach a purely foreign antitrust conspiracy (Global Reinsurance / Equitas)

27 March 2012 328

In a decision that may reverberate beyond the antitrust context, New York’s highest court - the Court of Appeals - held that the state’s antitrust statute lacks the extraterritorial scope to reach a purely foreign alleged antitrust conspiracy. The decision could have broad implications for (...)

George Paul, Jack Pace, Martin M. Toto The US DOJ opens an investigation about a possible collusion among various hedge funds that trade euro contracts

3 March 2010 398

According to published reports, the Antitrust Division of the US Department of Justice (DOJ) has opened an investigation into possible collusion among various hedge funds that trade euro contracts. The inquiry comes amid a sharp decline in the value of the euro, which has fallen approximately (...)

George Paul, Jack Pace, Joseph Angland, Mark J. Gidley, Martin M. Toto, Robert Milne The Department of Justice withdraws the report untitled Competition and Monopoly (Single-Firm Conduct under Section 2 of the Sherman Act that had been issued by the Division in September 2008)

11 May 2009 148

On May 11, 2009, the Antitrust Division of the Department of Justice (“DOJ”), in a speech by new Assistant Attorney General Christine A. Varney and a press release issued later in the day, formally withdrew the report entitled Competition and Monopoly: Single-Firm Conduct under Section 2 of (...)

Jack Pace, John Rue The US Congress amends FRCP rules concerning electronically stored information clarifying e-discovery in antitrust cases

1 December 2006 366

As any experienced litigator of complex civil cases can attest, clarifying (and potentially containing) the scope of discovery is a critical task. Regardless of the substantive law at issue, tremendous resources often are required to fulfill the duty to preserve and disclose relevant (...)

Statistics

6053

Total visits

504.4

Number of readings per contribution

Number of contributions

Author's ranking

829^th

In number of contributions

1569^th

In number of visits

4123^th

In average number of visits